Merck & Co., Inc. is a global research-driven pharmaceutical products company. Committed to bringing out the best in medicine
Contact usWorldwide
HomeAbout MerckProductsNewsroomInvestor InformationCareersResearchLicensingThe Merck Manuals

The Merck Manual--Second Home Edition logo
 
click here to go to the Index click here to go to the Table of Contents click here to go to the search page click here for purchasing information
Chapter 184. Immunodeficiency Disorders
Topics: Introduction | X-Linked Agammaglobulinemia | Selective Antibody Deficiency | Common Variable Immunodeficiency | Transient Hypogammaglobulinemia of Infancy | Chronic Mucocutaneous Candidiasis | DiGeorge Anomaly | Ataxia-Telangiectasia | Severe Combined Immunodeficiency Disease | Wiskott-Aldrich Syndrome | Hyperimmunoglobulinemia E Syndrome | Chronic Granulomatous Disease | Immunodeficiency due to Spleen Disorders
 
green line

Immunodeficiency due to Spleen Disorders

The spleen is crucial to the function of the immune system: The spleen traps and destroys bacteria and other infectious organisms in the bloodstream and produces antibodies. For people whose spleen is absent at birth, damaged, or removed because of disease, the risk of developing severe bacterial infections is increased.

People who do not have a spleen are given pneumococcal and meningococcal vaccines in addition to the usual childhood vaccines. People who have a spleen disorder or no spleen are given antibiotics at the first sign of infection. Children who do not have a spleen should take antibiotics continuously until at least age 5. An antibiotic, usually penicillin or ampicillin, is often given to prevent an infection in the bloodstream.

Site MapPrivacy PolicyTerms of UseCopyright 1995-2004 Merck & Co., Inc.